IDiyas

For the Inventor, By the Inventor

Framingham, MA, United States of America

Yaping Hong

USPTO Granted Patents = 13

 

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 234(Granted Patents)


Location History:

  • Worcester, MA (US) (1995 - 1997)
  • Princeton, NJ (US) (2003)
  • Framingham, MA (US) (1998 - 2005)

Company Filing History:

goldMedal13 out of 322 
 
Sepracor, Inc.
 patents

Years Active: 1995-2005

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 6946464 - Methods of treating and preventing a convulsive state (2005-09-20),
2. 6627646 - Norastemizole polymorphs (2003-09-30),
3. 6506753 - Methods of making and using N-desmethylzopiclone (2003-01-14),
4. 6458791 - Methods of treating muscle spasms using N-desmethylzopiclone (2002-10-01),
5. 6455530 - 2R,4S,S,S- and 2S,4R,S,S-hydroxyitraconazole (2002-09-24),
6. 6166018 - 2R, 4S, R, S- and 2S, 4R, R, S-hydroxyitraconazole (2000-12-26),
7. 5952502 - 2R,4S,R, S- and 2S,4R,R,S-hydroxyitraconazole (1999-09-14),
8. 5817823 - Method for synthesizing 2-substituted imidazoles (1998-10-06),
9. 5616808 - Optically pure 1-amino-2-indanols (1997-04-01),
10. 5599985 - Optically pure 1-amido-2-indanols (1997-02-04),
11. 5516943 - Process for preparing cyclic CIS-1-amino-2-alkanols (1996-05-14),
12. 5495054 - Tetrahydroindeno[1,2-D][1,3,2]oxazaboroles and their use as (1996-02-27),
13. 5442118 - Asymmetric synthesis of (R)- and (S)-arylethanolamines from iminoketones (1995-08-15),

Title: Yaping Hong: Innovator in Pharmaceutical Patents

Introduction

Yaping Hong is a prominent inventor based in Framingham, MA (US), known for his significant contributions to the pharmaceutical industry. With a total of 13 patents to his name, he has made remarkable advancements in the treatment and prevention of various medical conditions.

Latest Patents

Among his latest patents, one notable invention is focused on methods of treating and preventing a convulsive state. This invention involves compositions comprising racemic N-desmethylzopiclone, optically pure (+)-N-desmethylzopiclone, and optically pure (−)-N-desmethylzopiclone. The methods outlined in this patent aim to address diseases and conditions in mammals effectively. Another significant patent involves norastemizole polymorphs, which discloses polymorphic crystalline forms of the antihistaminic drug norasternizole. This patent also details processes for producing the preferred polymorph.

Career Highlights

Yaping Hong has established a successful career at Sepracor, Inc., where he has been instrumental in developing innovative pharmaceutical solutions. His work has not only contributed to the company's growth but has also advanced the field of medicine.

Collaborations

Throughout his career, Yaping has collaborated with notable colleagues, including Roger P Bakale and Yun Gao, who have contributed to his research and development efforts.

Conclusion

Yaping Hong's innovative work in pharmaceuticals, particularly in the area of convulsive state treatments and antihistaminic drugs, showcases his dedication to improving healthcare. His contributions through patents reflect his commitment to advancing medical science and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…